- Home
- SNES vs COCH Comparison
SNES vs COCH Comparison
Compare SNES & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNES
- COCH
- Stock Information
- Founded
- SNES 2004
- COCH 1995
- Country
- SNES United States
- COCH United States
- Employees
- SNES N/A
- COCH N/A
- Industry
- SNES Agricultural Chemicals
- COCH Blank Checks
- Sector
- SNES Industrials
- COCH Finance
- Exchange
- SNES Nasdaq
- COCH Nasdaq
- Market Cap
- SNES 24.0M
- COCH 19.2M
- IPO Year
- SNES 2016
- COCH N/A
- Fundamental
- Price
- SNES $3.77
- COCH $0.84
- Analyst Decision
- SNES Strong Buy
- COCH Strong Buy
- Analyst Count
- SNES 1
- COCH 2
- Target Price
- SNES $10.00
- COCH $9.25
- AVG Volume (30 Days)
- SNES 103.7K
- COCH 8.5M
- Earning Date
- SNES 11-11-2025
- COCH 11-13-2025
- Dividend Yield
- SNES N/A
- COCH N/A
- EPS Growth
- SNES N/A
- COCH N/A
- EPS
- SNES N/A
- COCH N/A
- Revenue
- SNES $2,093,000.00
- COCH $222,000.00
- Revenue This Year
- SNES $49.17
- COCH $3.66
- Revenue Next Year
- SNES $89.89
- COCH $31.19
- P/E Ratio
- SNES N/A
- COCH N/A
- Revenue Growth
- SNES 36.89
- COCH N/A
- 52 Week Low
- SNES $1.30
- COCH $0.74
- 52 Week High
- SNES $6.24
- COCH $3.09
- Technical
- Relative Strength Index (RSI)
- SNES 42.31
- COCH 43.60
- Support Level
- SNES $3.60
- COCH $0.77
- Resistance Level
- SNES $3.90
- COCH $0.88
- Average True Range (ATR)
- SNES 0.27
- COCH 0.11
- MACD
- SNES -0.02
- COCH 0.01
- Stochastic Oscillator
- SNES 20.48
- COCH 6.25
About SNES SenesTech Inc.
SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.